Search

everythinglearnresearchcommunity

for

Search:↓

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

The study concluded that different treatments reduced post-COVID symptoms over time and that factors like age, severity, and comorbidities affect symptom risk.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

The document concludes that rapid identification, isolation, and strict infection control are crucial to manage SARS outbreaks.

COVID-19 vaccination may trigger lupus in some people.

Children generally have milder SARS symptoms than adults, with good outcomes and no deaths reported, but long-term effects are unclear.

COVID-19 can cause various skin problems, including reactions to protective gear and medication, with different rates reported worldwide, and more research is needed to fully understand these skin issues.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

No single biomarker is reliable enough for diagnosing and assessing SLE.

SLVs help maintain muscle stretch sensitivity and could aid in treating hypertension and muscle spasticity.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

Lupus affects the skin in various ways, and proper skin examination is crucial for diagnosis and treatment.

New therapies are being developed that target integrin pathways to treat various diseases.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

COVID-19 may harm male fertility and damage the reproductive system.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

Different small areas within hair follicles send specific signals that control what type of cells stem cells become.

Eating a high-fat fish oil diet caused mice to lose hair due to a specific immune cell activity in the skin linked to a protein called E-FABP.

Long COVID affects over half of COVID-19 survivors, causing a range of symptoms like fatigue and neurological issues, with no specific treatment yet.

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.

The research found that different types of fibroblasts are involved in wound healing and that some blood cells can turn into fat cells during this process.

TRPA1 is crucial for mechanical sensitivity in skin sensory neurons.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

COVID-19 might affect male fertility, but more research is needed to understand the full impact.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Probe detects finasteride with high selectivity and low detection limit.